Market Place
Sourcing Support
Natco`s Rs1,290 Semaglutide Slashes Diabetes Drug Prices in India
20 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Breckenridge Launches Pomalidomide Capsules
03 Mar 2026 //
PRESS RELEASE
Semaglutide Patent Expiry Slashes India`s Weight-Loss Drug Prices
25 Feb 2026 //
ECONOMICTIMES
NATCO Receives CDSCO Approval For Semaglutide In India
15 Feb 2026 //
INDPHARMAPOST
NATCO Receives Fda`s Tentative Approval For Erdafitinib Tablets
04 Feb 2026 //
INDPHARMAPOST
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
HC Seeks Novo Nordisk`s Reply On Natco Plea To Revoke Patent
06 Jan 2026 //
ECONOMICTIMES
Indian Firms Selected To Supply Generic Drugs In China
12 Nov 2025 //
ECONOMICTIMES
Breckenridge Launches 1mg Everolimus Tablets, Generic Zortress
30 Oct 2025 //
PR NEWSWIRE
Roche`s Appeal Denied By Supreme Court In Risdiplam Generic Drug
17 Oct 2025 //
BUSINESS STD
Roche Challenges Natco`s Generic Risdiplam Launch In India
14 Oct 2025 //
ECONOMICTIMES
Natco Wins Patent Battle To Launch Generic `Risdiplam`
11 Oct 2025 //
ECONOMICTIMES
Natco Pharma Sues Novo Nordisk Over Generic Drug Push
21 Aug 2025 //
ECONOMICTIMES
Natco Debuts Bosentan Tablets in Us with 180-Day Exclusivity
21 Aug 2025 //
INDPHARMAPOST
NATCO Pharma updates on legal proceedings for Risdiplam launch
08 Apr 2025 //
INDPHARMAPOST
Natco submits ANDA with USFDA for Risdiplam for Oral solution
21 Nov 2024 //
BUSINESS STD
Natco shares rise 4% order in US patent case over generic Ozempic
07 Oct 2024 //
MONEYCONTROL
Natco Pharma, others sued in US for generic cancer drug
08 Sep 2023 //
ECONOMIC TIMES
Natco Pharma launches additional strengths of generic version of Revlimid in US
10 Mar 2023 //
ECONOMIC TIMES
Natco Pharma submits application with USFDA for generic cancer drug
13 Feb 2023 //
ECONOMIC TIMES
Taiho Pharmaceuticals moves US court against Natco on generic cancer drug
03 Jan 2020 //
ECONOMICTIMES
Lupin-Natco get USFDA nod to market generic hypertension drug
30 Apr 2019 //
MONEYCONTROL
Pomalyst (Pomalidomide) : Celgene Corp. vs. Breckenridge Pharma
19 Oct 2018 //
PATENT LITIGATION
Natco`s partner Mylan prevails over Teva in Copaxone patent litigation
13 Oct 2018 //
MONEY CONTROL
Sanofi bets big on India
29 Aug 2018 //
MANUFACTURING CHEMIST
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
31 Jul 2018 //
BUSINESS STANDARD
Dying to Survive: Indian generic medicines have a tale to tell
19 Jul 2018 //
BUSINESS TODAY
How A Drugmaker Gamed The System To Keep Generic Competition Away
17 May 2018 //
NPR
Sovaldi® (Sofosbuvir) : Gilead Sciences, v. Natco Pharma Limited
14 Mar 2018 //
PATENT LITIGATION
Natco Pharma’s generic pipeline delivers a blockbuster
04 Oct 2017 //
LIVEMINT
“Natco profits to depend on how many rivals get nod for the generic MS drug”
03 Oct 2017 //
ECONOMIC TIMES
NATCO receives FDA approval for Vidaza for USA market
28 Jun 2017 //
BIOSPECTRUM
Natco Pharma receives USFDA’s final approval for generic azacitidine
26 Jun 2017 //
INDIA INFOLINE
USPTO Files Response Brief in In re Janssen Biotech, Inc. & New York University
15 May 2017 //
PRESS RELEASE
Natco Pharma launches generic hepatitis C drug in India
08 May 2017 //
BUSINESS-STANDARD
Multiple growth pills should keep Natco Pharma`s revenue charts healthy
15 Apr 2017 //
BUSINESS-STANDARD
Delhi Court favours Natco,Alembic; allows to export generics of Bayer`s drugs
08 Mar 2017 //
ECONOMIC TIMES
Generic Copy of Roche Flu Pill Tamiflu hits US Market
13 Dec 2016 //
REUTERS
Natco Pharma gets USFDA Nod for Generic Budesonide Capsules
25 Nov 2016 //
ECONOMIC TIMES
Celgene to allow sale of generic Revlimid before patent expiry
24 Dec 2015 //
REUTERS
Natco eyes U.S. FDA green light for Copaxone generic sales
22 Jun 2015 //
FIERCE PHARMA ASIA
